Factors influencing sodium and water excretion in uremic man  by Yeh, Betty P.Y. et al.
Kidney international, Vol. 7 (1975), p. 103-410
Factors influencing sodium and water excretion in
uremic man
BETTY P. Y. YEH, DAVID J. TOMKO, WILLIAM K. STACY, EDWARD S. BEAR,
HALCOTT T. HADEN and WILLIAM F. FALLS, JR.
Medical Service, Veterans Administration Hospital and Department of Medicine, Medical College of Virginia, Health Sciences
Division, Virginia Commonwealth University, Richmond, Virginia
Factors influencing sodium and water excretion in uremic man.
Urinary excretion of sodium and water was investigated in
patients with chronic end-stage renal disease before and after
three different experimental manipulations: reduction in urea
solute load by dialysis while extracellular fluid volume (ECFV)
was maintained, dialysis without alteration in urea solute load or
ECFV and reduction in ECFV without alteration in urea solute
load. Sodium and water excretion significantly declined in
association with a reduction in both urea solute load and ECFV,
but not during a dialysis when reduction on both of these in-
dexes was prevented. The excretory changes occurred in the
absence of any alteration in creatinine clearance. The studies
suggest that both solute load and the degree of extracellular fluid
volume expansion contribute independently to the rate of sodium
and water excretion in chronic renal disease. It is concluded that
in any given patient the overall excretion of sodium and water is
directly influenced by a number of factors including the solute
load, the degree of ECFV and the glomerular filtration rate.
Facteurs qui influencent l'excrétion d'eau et de sodium chez
l'homme urémique. L'excrétion urinaire de sodium et d'eau a été
étudiée chez des malades atteints de néphropathie chronique au
stade terminal avant et aprês trois manoeuvres expérimentales:
reduction de Ia masse d'urée par dialyse cependant que le volume
extracellulaire (ECVF) était maintenu, dialyse sans modification
de Ia masse d'urée ou d'ECVF, reduction d'ECVF sans modi-
fication de Ia masse d'urée. L'excrétion d'eau et de sodium di-
minue significativement lors de Ia reduction simultanée de Ia
masse d'urée et d'ECVF, mais n'est pas modifiée per Ia dialyse
quand les deux paramétres ci-dessus sont maintenus constants.
Les modifications excrétoires surviennent en I'absence de tout
changement de Ia clearance de Ia créatinine. Ces travaux sug-
gèrent qu'à Ia fois Ia charge de solute et le degré d'expansion
extracellulaire contribuent indépendamment aux debits d'excré-
tion de sodium et d'eau dans Pinsuffisance rénale chronique. II
est conclu que chez un malade donné, l'excrétion globale d'eau
et de sodium est directement influencée par divers facteurs dont
Ia charge de substances dissoutes, le degre d'expansion du volume
extracellulaire et le debit de filtration glomerulaire.
Sodium and water excretion in normal animals and
man is finely controlled by the complex interplay of
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various hormonal, hemodynamic and physio-chemical
factors [1]. Despite the loss of a major portion of the
functioning nephron mass, uremic subjects largely
maintain the ability to modulate sodium excretion in
relation to intake [2], thus suggesting at least partial re-
tention of some control mechanisms.
A complete understanding of the mechanisms of
adaptation which allow the residual nephrons of the
damaged kidney to handle sodium loads has not yet
been attained. Disagreement exists among investigators
about the relative importance of the several factors
which are suspected of being operative in controlling
sodium excretion in uremia. Some investigators [3—5]
feel that the osmotic effect of an increased solute load,
composed primarily of urea and other nonreabsorb-
able substances, plays a major role in enhancing the
excretion of sodium and water. Others [6—8] have rel-
egated this mechanism to a position of minimal im-
portance and instead relate the excretory changes to
some factor inherent in the uremic state which en-
hances sodium and water excretion. A circulating in-
hibitor to sodium reabsorption has been recently
identified in uremic serum [9]. However, whether this
factor is generated by the uremic state, per Se, or as a
response to the extracellular fluid volume (ECFV) ex-
pansion which usually accompanies renal failure is
uncertain [10]. Furthermore, it is unclear whether the
well recognized effect of ECFV expansion is mediated
primarily through an inhibition of proximal or distal
tubular reabsorptive processes [6, 8, 11] or via renal
hyperperfusion and an increased glomerular filtration
rate (GFR) secondary to blood pressure elevation [12]
The present study was undertaken to dissociate and
examine separately the effects of solute load and
ECFV expansion on sodium and water excretion in a
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group of patients with chronic renal failure. In the
process of examining the influence of ECFV alone,
some observations were also made on the relation of
this index to blood pressure changes.
Methods
Patients selected. Twenty-eight patients with chronic
end-stage renal failure of varying etiologies (Table 1)
were studied at the McGuire Veterans Administration
Hospital. Twenty-seven of the patients were either en-
rolled or being evaluated for acceptance into a re-
petitive hemodialysis program when they entered the
study. One was receiving repetitive peritoneal dialysis.
Informed consent was obtained from each patient
prior to the institution of the investigation. All patients
were receiving dietary protein restriction (40 to 80 g/
24 hr), aluminum hydroxide gels, vitamin supplements
and in most cases modest dietary sodium restriction
(44 to 125 mEq/24 hr). None of the patients were tak-
ing diuretics at the time of the study, but several were
undergoing treatment for hypertension with alpha-
methyldopa (Aldomet). None showed clinical evidence
of pulmonary congestion. Most of the hemodialysis
patients were considered candidates for renal trans-
plantation and demonstrated complete bladder empty-
ing by voiding cystography. The peritoneal dialysis
patient showed adequate bladder function by having a
negligible residual urine volume after spontaneous
voiding. One paraplegic, hemodialysis patient had
urine collected from a nephrostomy tube and an in-
dwelling Foley catheter.
Studies performed. Measurements of blood pressure,
body wt, plasma urea nitrogen concentration (PUN),
plasma osmolality (Posm), serum electrolyte concentra-
tions, urine osmolality and ECFV (35S space) were
made at several points in the course of dialysis as out-
lined in the following. Because of variability in the
volume of urine excreted, collection periods varied
from 1 to 24 hr, but all were accurately timed and a
plasma specimen was obtained at approximately the
midpoint of each period for use in clearance calcula-
tions. No meals were withheld during the initial or
later studies and the patients were allowed to have
fluids ad lib but were not water-loaded. It was assumed
that urinary excretion in these patients with severe
Table I. Clinical information concerning study patients
Patient
No.
Age
yr
Creatinine
clearance
mI/mm
Blood
pressure
mm Hg
Cause of renal disease
1 35 2.8 120/80 Pyelonephritis, congenital anomaly
2 45 7.5 110/70 Polycystic
3 39 8.9 135/70 Chronic glomerulonephritis5
4 50 8.5 170/100 Nephrosclerosis5
5 34 2.5 160/90 Nephrosclerosisa
6 48 6,2 210/120 Nephrosclerosis
7 48 8.7 160/90 Chronic pyelonephritis, amyIoidosis
8 32 8.0 120/90 Polycystic
9 35 4.2 200/140 Nephrosclerosis'
10 38 9.4 134/80 Polycystic
11 53 3.9 160/60 Polycystic
12 50 3.7 120/80 Polycystica
13 42 2.8 160/80 Chronicglomeruionephritis
14 35 0.7 200/130 Nephrosclerosis
15 55 7.6 150/90 Chronic glomerulonephritis
16 50 12.6 200/110 Nephrosclerosis5
17 56 4.9 150/90 Polycystic
18 50 6.8 130/90 Po1ycystic
19 51 4.6 130/90 Chronic g1omerulonephritis
20 36 2.7 130/80 Chronic glomerulonephritis
21 59 1.6 185/100 Chronic glomerulonephritis
22 25 1.0 200/120 Chronic glomerulonephritis
23 47 4.5 140/90 Chronic glomerulonephritis
24 49 3.9 140/90 Chronic glomerulonephritis
25 48 5.5 122/70 Chronic glomerulonephritis
26 50 7.4 182/90 Chronic glomeru1onephritis
27 21 2.4 110/70 Chronic glomerulonephritis
28 50 2.6 180/90 Chronic glomeru1onephritis
Mean 43.9 5.2
Diagnosis confirmed by histologic evaluation.
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renal insufficiency would not be significantly influenced
by mild variations in fluid intake.
Plan of investigation. 1) Group I: Evaluation of the
influence of solute load. In nine patients with minimal
evidence of clinical volume expansion, the indexes
already mentioned herein were initially measured prior
to any dialysis when the patient was assumed to have
a high load of retained solutes. After baseline data had
been obtained, the patients underwent a hemodialysis
during which fluids were given i.v. and orally in
amounts calculated to maintain body wt constant.
This was done in an effort to vary solute load by
dialysis while maintaining ECFV constant. Repeat 35S
space, creatinine clearance and electrolyte excretion
were then measured after dialysis. It was discovered
early that 35S space measurements decreased in most
patients despite maintenance of body wt, and that
ECFV could be maintained only by giving sufficient
fluids to increase body wt by an average of 0.4 kg in
these individuals. Therefore, those patients with a
postdialytic reduction in 35S space underwent further
dialysis during which more fluid was administered un-
til the postdialysis ECFV was equal to or slightly
greater than the original determinations. Four patients
who had received prior dialysis were initially studied
immediately after dialysis and again several days later
when the solute load had reattained a high level but
ECFV was still low because of careful fluid and
sodium restriction. In this manner urinary excretion
was examined in 13 patients at two greatly different
solute loads but relatively comparable levels of ECFV.
2) Group II: Evaluation of the influence of dialysis
alone. Because of the possibility that any urinary ex-
cretory change noted in group I patients might be
related to the dialysis itself rather than to alteration in
the solute load, seven patients were subjected to
dialysis against a bath to which urea was added in an
amount calculated to maintain the bath concentration
the same as plasma. During dialysis in this group, fluid
intake was also carefully controlled to avoid either a
significant increase or reduction in the ECFV.
3) Group III: Evaluation of the influence of the level
of ECF V—its relation to blood pressure and GFR. In
14 patients (4 of whom were also included in group I)
determinations of blood pressure, 35S space, creatinine
clearance and electrolyte excretion were made at two
different points in time; once when the ECFV was
high, and again when it was lower but the level of
azotemia was essentially the same.
Dialysis methods. Hemodialyses were performed for
four to eight hours using a Milton-Roy central dialys-
ate delivery system with a variety of dialyzers including
the modified Kiil, Dow hollow fiber, Gambro-Lundia
and Travenol Ultra-flow 145 coil in groups I and III.
All dialyses in group II were performed with a single-
pass recirculating system using a Travenol RSP
dialyzer and a Travenol Ultra-flow 145 coil. It was
assumed for the purposes of this study that the func-
tion of all of the dialyzers was qualitatively similar.
Analytical and statistical methods. 35S space was de-
termined by a modification of the method of Walser,
Seldin and Grollman [13]. Plasma was collected at 30,
45, 60 and 90 mm after injection of 60 to 90 1iCi of 35S.
Isotope counting was done in a liquid scintillation
counter (Nuclear-Chicago) and counts at zero time
calculated by the method of least squares on a com-
puter (IBM 370). 5S space was then determined from
the following formula:
Volume of distribution
—
Counts per minute of standard x dilution x 0.90
Counts per minute per ml of plasma water
The factor of 0.90 was used as the Donnan factor for
the sulfate ion. Plasma and urine creatinine, urea
nitrogen and electrolyte determinations were made by
methods routine to this laboratory [14]. Blood pres-
sure was measured with a sphygmomanometer and
mean pressure calculated as diastolic pressure plus one-
third pulse pressure. The data from the control and
experimental period were compared in each group and
subjected to statistical analysis by a standard paired
t test programmed on a computer (IBM 370).
Results
Clinical state of patients. Table I provides clinical
information about the patients involved in the study.
It is worthy of note that the etiologic processes in this
group of patients encompassed a wide spectrum of
end-stage renal disease and included processes which
are considered to be primarily destructive to both the
glomerular and tubular portions of the nephron.
Diagnosis was made in most cases by evaluation of the
clinical and roentgenographic picture and was con-
firmed in 14 by pathologic evaluation at biopsy, neph-
rectomy or necropsy. GFR as indicated by the creati-
nine clearance varied from 0.7 to 12.6 mI/mm with a
mean of 5.2 mI/mm. All patients had evidence of a
uremic syndrome and required dialysis therapy. Blood
pressure varied from normal to high levels but was
highest in those patients with malignant nephro-
sclerosis.
Evaluation of the influence of solute load on urinary
excretion. The data from group I patients (Table 2,
Fig. 1) show that dialysis produced a significant re-
duction in solute load as reflected by the decline in
mean PUN from 115 to 62 mg/l00 ml, Posm from 330
to 302 mOsm/kg, urine osmotic excretion (UosmV)
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Table 2. Comparison of mean SD baseline and experimental values in group I patients (solute load reduced; ECFV maintained in the
experimental period)
ECFV Urine Creati- Plasma Plasma Plasma Sodium Osmotic Urea Frac- Mean
ml volume nine urea osmo- sodium excretion excretion nitrogen tional blood
mi/mm clearance nitrogen lality mEq/Iiter jEq/mmn fLOsm/min excretion reab- pressure
mi/mm mg/100 ml mOsm/kg mg/mm sorption mm Hg
of
sodium
O/
High 13038 1.04 6.1 115 330 137 50.2 286 3.7 93.2 116
soluteload ±2454 ±0.47 ±2.5 ±40 ±17 ±4 ±28.2 ±119 ±1.9 ±4.3 ±28
Low 13495 0.82 6.4 62 302 135 29.9 168 1.8 96.1 119
soluteload ±2506 ±0.39 ±2.5 ±32 ±19 ±5 ±19.1 ±80 ±0.8 ±2,5 ±29
P <0.02 <0.02 NS <0.001 <0.001 NS <0.01 <0.001 <0.001 <0.01 NS
from 286 to 168 iOsm/min and urine urea nitrogen
excretion (tJreaV) from 3.7 to 1.8 mg/ mi ECVF was
slightly increased (P <0.02) by the fluids administered
during dialysis. Mean creatinine clearance remained at
essentially predialysis levels in association with the
maintenance of ECFV. Plasma sodium concentration
and blood pressure measurements were not signi-
ficantly altered by dialysis. Fig. 1 illustrates the changes
in sodium excretion (UNaV) and fractional reabsorption
of sodium in each patient. Mean values for these in-
dexes as seen in Table 2 showed a significant fall in
urine volume (UV) from 1.04 to 0.82 ml/min(P<0.02)
and sodium excretion (UNaV) from 50.2 to 29.9 p.Eq/
mm (P<0.0l). The reduction in sodium excretion was
a direct result of enhanced tubular reabsorption as in-
dicated by the increased fractional reabsorption of
sodium from 93.3 to 96.0% in the face of maintained
creatinine clearance. These excretory alterations be-
come even more striking when it is realized that ECFV
actually rose slightly, a trend that might have tended
to offset changes related to the reduction in solute
load. These data, thus, indicate that the fall in water
and sodium excretion following dialysis correlates
closely with the reduction in solute load.
Factors other than solute load must also have been
altered by the dialytic process. Therefore, in order to
maintain constancy of urea, the major osmotically
active solute, group II patients were evaluated before
and after dialysis against a high urea bath. Fig. 2
illustrates the changes in UNaV and fractional reab-
sorption of sodium for individual patients. Table 3
shows that with maintenance of the solute load by
adding urea to the dialysis bath, there was no signi-
ficant change in mean V, UNaY, UosmV, UureaV, Cereat,
PUN, fractional reabsorption of sodium or BP during
the dialysis period. A slight but significant reduction in
Poem occurred, probably reflecting the dialysis of other
nonurea solutes; and a slight fall in PNa was seen as a
result of dialysis against a slightly lower concentration
of sodium in the bath. Thus, consideration of the data
from both groups I and II suggests that the reduction
in urine volume and sodium excretion which follows
dialysis in the ECFV-maintained patient is a conse-
quence of the change in solute load per se rather than
of some other dialysis-induced perturbation.
Evaluation of the influence of ECFV on urinary ex-
cretion. Table 4 and Fig. 3 display the data from
group III patients in whom solute load remained con-
stant as ECFV decreased. Significant reductions in
V (0.98 to 0.73 mI/mm, P<0.0l) and UNaV (50.0 to
140
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Fig. 1. Urine Na excretion (UN V) and fractional reabsorption of
Na in group 1 patients.
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31.5 Eq/min, P <0.001) and an increase in fractional
reabsorption of sodium from 93.6% to 95.5% (P<
0.01) occurred in conjunction with the fall in ECFV.
Despite the major change in mean ECFV from 16,344
to 14,054ml, there was no significant alteration in GFR
(Coreat). This lack of change was undoubtedly related
to the fact that the ECFV remained relatively ex-
panded [13] even though it was reduced from an even
higher level in most patients. The reduction in ECFV
was associated with a slight reduction in mean blood
pressure from 117±24 to 109±21 mm Hg(P<0.Ol),
however. These findings are compatible with the con-
cept that when the influence of differing solute loads is
removed, sodium and water excretion is influenced
directly by the level of ECFY, being greater with a
more expanded ECFV. Additionally, since the reduc-
tion in sodium and water excretion occurred in the
absence of a change in GFR, the increased fractional
reabsorption of sodium must have been produced by
an enhancement of the intrinsic reabsorptive capacity
of the tubules.
Discussion
_______
Despite the loss of a major portion of the nephron
mass, many patients with chronic end-stage renal
disease continue to excrete sufficient sodium and water
to balance the daily intake [2, 6, 15, 16]. This ability of
Table 3. Comparison of mean baseline and experimental values in group II patients (dialysis; solute load maintained constant in
experimental period with a high urea bath)
ECFV Urine Creati- Plasma Plasma Plasma Sodium Osmotic Urea Frac- Mean
ml volume nine urea osmol- sodium excretion excretion nitrogen tional blood
mi/mi,: clearance nitrogen ality mEq/liter Eq/min Osm/min excretion reabsorp- pressure
mi/mi,: mg/loom! mOsm/kg mg/mm tion of mm Hg
sodium
O/
Baseline 16034 0.62 3.9 118 336 135 38.0 201 2.4 94.0 107
After dialysis 16034 0.59 3.9 124 331 132 32.7 185 2.4 94.2 110
P NS NS NS NS <0.01 <0.05 NS NS NS NS NS
Table 4. Comparison of mean SD baseline and experimental values in group III patients (solute load maintained, ECFV reduced in
the experimental period)
ECFV Urine Creatinine Plasma Sodium Fractional Plasma Mean
ml volume clearance urea excretion reabsorption sodium blood
mi/mm mi/mi,i nitrogen tEq/mmn of sodium mEg/liter pressure
mg/IOO ml % mm Hg
High ECFV
Reduced ECFV
16344
14054
0.98
0.73
5.6
5.4
70.1
73.9
50.0
31.5
93.6
95.5
135
134
117
109
p <0.001 <0.01 NS NS <0.001 <0.01 NS <0.01
<0
100
140 —
120 95
100
z
8
•0
-8O 90
z
60
40 85
20
0 80
Fig. 2. Urine excretion (UNO V) and fractional reabsorption of Na
in group I! patients.
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the damaged kidney to maintain fluid and electrolyte
homeostasis is dependent on an adaptive reduction in
the fractional reabsorption of filtrate by the residual
nephrons. The origin of such an adaptive change is in-
completely defined, but by analogy to the normal state
of sodium and water homeostasis [1, 101 is likely to be
modulated by several interacting factors rather than be
explained by a single mechanism [9].
Initially it was suggested that the reabsorptive
adaptation was the result of a urea, solute diuresis [2,
17, 18]. Support for this concept was found by ob-
servation of the diuresis in animals [19] and humans
[16] subjected to urea infusions; by the micropuncture
studies of Hayslett, Kashgarian and Epstein in uremic
rats [4]; and by the demonstration of Coleman et al [3]
that sodium wasting in chronic renal disease is related
to an inhibition of the maximal concentration gradient
for sodium in the distal tubule by an increase in osmo-
tically active, nonreabsorbable solute in that portion
of the nephron.
Skepticism about the role of a urea diuresis in en-
hancing sodium and water excretion in chronic renal
failure has been raised because of two recent develop-
ments: 1) reevaluation of the techniques used in early
studies of urea diuresis has indicated con.tamination by
an element of ECFY expansion [20]; 2) suggestive
evidence for a factor or factors which may directly in-
hibit tubular sodium transport has been found in the
uremic state [9]. Results from the former studies do
not exclude urea, osmotic diuresis from a partial or
contributory role, however; and the influence of the
uremic state has not been clearly dissociated from
changes in the degree of ECFV expansion in the latter
investigations (vide infra) [6, 10, 11].
ECFV expansion frequently accompanies chronic
renal failure as attested by the high ECFV levels ob-
served in many of the patients in this study and by
measurement of fluid spaces by others [21, 22]. Expan-
sion of the ECFV may enhance sodium excretion by
several different mechanisms: 1) by elevation of syste-
mic blood pressure [12]; 2) by inhibition of endogenous
aldosterone secretion, although current evidence sug-
gests that this may seldom be the case in patients with
severe renal insufficiency [5, 6, 11]; and 3) perhaps
most important, by release of a circulating humoral
factor which acts to inhibit reabsorptive processes in
the proximal tubule [6, 9, 10] in the expanded and ure-
mic state.
The present study was designed to dissociate the in-
fluence of ECFV expansion and solute load on sodium
and water excretion in uremic patients and to determine
the role played by each independently. The data in-
dicate that in men with chronic renal insufficiency both
solute load and the level of ECFV expansion contri-
bute significantly and separately to the role of sodium
and water excretion.
The role of solute load is strongly suggested by con-
sideration of the data from group I and II patients. In
group I the PUN and Posm were reduced by dialysis
while ECFV was slightly raised by sodium and fluid
administration (Table 2). Sodium and water excretion
diminished despite the slight elevation in mean ECFV
(Table 2, Fig. 1). A dialysis-induced alteration other
than that of osmotic load seemed less likely in view of
the fact that a significant change in sodium and water
excretion was not observed when a high solute load
was maintained by dialysis against a high urea bath
(group II) (Table 3, Fig. 2). Thus, the osmotic effect of
an increased solute load (primarily urea) can be identi-
fied as a major influence tending to enhance sodium
excretion in chronic renal insufficiency.
The data in group III patients clearly indicate that at
a constant solute load and GFR, more sodium and
water was excreted in the expanded state. No definite
statement can be made as to the mechanisms whereby
ECFV expansion leads to increased excretion, whether
100
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Fig. 3. Urine Na excretion (UNaV) and fractional reabsorption of
Na in group III patients,
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to an inhibition of aldosterone activity or to increased
release of a circulating humoral factor, or both.
Sodium excretory changes could not be related to
alterations in GFR because none were noted during
the study. A small but significant reduction in blood
pressure was noted, however, in conjunction with the
fall in ECFV induced in group III patients. It is pos-
sible that this change may have resulted in unmeasured
alterations of renal hemodynamics which in turn in-
fluence sodium and water reabsorption [23].
The results of the present study in no way preclude
the operation of a circulating humoral factOr which
might act to inhibit renal tubular sodium reabsorption
in uremic patients. It is possible that such a factor was
present during the studies of group I and II patients
but its action was uninfluenced by dialysis. Even if it
were influenced by dialysis, however, its effect could
have been masked by the wide scatter of the data in
group 11 patients. Since ECFV expansion was present in
group II patients both before and after dialysis, it may
be that a circulating humoral factor, responsive to
volume changes, was present throughout the study.
Furthermore, the data in group 111 patients are en-
tirely compatible with the action of an expansion-
induced circulating humoral factor controlled by the
level of ECFV expansion.
Overall analysis of the data presented in this in-
vestigation strongly suggests that both solute load and
the degree of ECFV expansion are of importance in
controlling sodium and water excretion in patients with
chronic renal failure. This is not meant to imply, how-
ever, that these are the only factors which may be
operative. There is good evidence to indicate that re-
duction of ECFV below the expanded range will tend
to cause sodium retention because of a concomitant
fall in blood pressure with consequent reduction in
renal perfusion and GFR [12]. Thus, it would appear
that the dramatic reduction in urinary output and
sodium excretion experienced by virtually all patients
after initiation of dialysis [2, 17, 18] is a manifestation
of the conjoint effects of a fall in ECFV, GFR and
solute load. Conversely, it would seem reasonable to
postulate that the adaptation which allows many ure-
mic subjects to excrete relatively large amounts of
sodium prior to dialysis must be related to an elevation
of all of the above-mentioned factors acting in concert.
Whether or not some other factor related to loss of
nephron mass, per Se, may be operative in the uremic
state cannot be ascertained with certainty from this
study.
It is apparent that maximal excretion of sodium and
water by the patient with chronic renal insufficiency
can be attained only at the expense of both marked
azotemia and ECFV expansion. Furthermore, a major
reduction in ECFV in the patient with chronic renal
failure will almost certainly lead to a fall in blood pres-
sure and GFR and, consequently, further reduce
sodium excretion. Thus, the clinician can adequately
judge a patient's tolerance for sodium and water only
in the context of his state of volume expansion and
degree of azotemia.
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